Signaling pathways
-
BA5423 RepirinastSummary: Repirinast (MY-5116) is an orally active antiallergic agent. - BA5424 IrdabisantSummary: Irdabisant (CEP-26401) is a selective, orally active and blood-brain barrier permeable histamine H3 receptor (,H3R) antagonist/inverse agonist with 7.2 nM and 2.0 nM for rat H3R and human H3R, respectively.
- BA5425 CipralisantSummary: Cipralisant (GT-2331) is an orally active, low-toxicity, potent, selective, high-affinity antagonist in vivo and agonist in vitro.
- BA5426 JNJ10191584Summary: JNJ10191584 (VUF6002) is an orally active, selective histamine antagonist.
- BA5427 AcrivastineSummary: Short-acting receptor antagonists for the study of allergic rhinitis.
- BA5428 NiperotidineSummary: A histamine H2 receptor antagonist.
- BA5429 ABT-239Summary: ABT-239 is a novelty.
- BA5431 LML134Summary: LML134 (compound 18b) is an orally active, highly selective (histamine 3 receptor) inverse agonist.
- BA5432 JZP-361Summary: JZP-361 is a potent, reversible and selective inhibitor of human recombinant (hMAGL).
- BA5433 PF-03654764Summary: PF-03654764 is an orally active, selective histamine receptor antagonist.